$320 billion by 2028, Great Place To Work said in its latest report on the pharmaceuticals, healthcare, and biotechnology sectors. (Representational image: Pixabay) 
Biotechnology

$320 billion by 2028, Future of Healthcare Industry in India

Report by Great Place To Work estimates that India's pharmaceutical sector will reach $130 billion by 2030, and biotechnology is planning for $300 billion by the same year.

MBT Desk

With the healthcare industry expected to exceed USD 320 billion by 2028, India's pharmaceutical, biotechnology and healthcare industries are poised for historically strong development.

By 2030, the pharmaceutical business targets for $130 billion, while the biotechnology sector plans to $150 billion by 2025 and $300 billion. A recent Great Place To Work study emphasises on workforce development to be considered for advancements in technology.

Up from 73% the previous year, 85% of the top workplaces in 2024 made investments in employee advancement initiatives. Companies must intensify their efforts to build professional development routes, produce leaders who are prepared for the future, and improve their methods for luring and keeping top personnel if they want to stay ahead, the report continued.

Globalization and talent-driven growth

The biotechnology, pharmaceutical, and healthcare sectors have experienced significant changes in the past twelve months.

The highlights in the trends are:

Globalization: Strong expansion in partnerships and exports.

Industry consolidation: Efficiency is being driven by mergers and acquisitions.

Investing in talent: Using India's highly qualified labor pool to spur innovation.

According to the Great Place To Work report, companies are also focussing more on strategic talent retention, leadership development, and employee development in order to match workforce objectives with technical innovations like Artificial Intelligence (AI).

Up from 73% the previous year, 85% of the top workplaces in 2024 made investments in employee advancement initiatives.

Prioritising employee development

"The pandemic accelerated innovation, but the marathon continues," stated Balbir Singh, executive director and CEO of Great Place To Work, India, about industry developments." India is producing dynamic workplaces that foster talent in addition to advancing research, with healthcare AI investments predicted to reach $1.6 billion by 2025."

Biotechnology industry is aiming for $300 billion by 2030. (Unsplash)
The pandemic accelerated innovation, but the marathon continues. India is producing dynamic workplaces that foster talent in addition to advancing research, with healthcare AI investments predicted to reach $1.6 billion by 2025.
Balbir Singh, Executive Director and CEO of Great Place To Work, India

Industry-driven complications and accomplishments

1. Healthcare have Leveraging technology and flexible work models to drive efficiency.

A room for improvement in

  • Equitably recruiting from under-represented areas and competency-based hiring.

  • Continuous learning opportunities.

2. Pharmaceuticals exhibited excellence in

  • Performance-based advancement.

  • Skill development, and mentoring.

 To enhance productivity

  • Leverage AI tools.

  • Transparent decision-making.

  • Tailored training.

3. Biotechnology thrived on

  • Rotational training.

  • Upskilling and hands-on certifications. 

Companies require

  • Career-specific academies.

  • Individualised onboarding with leadership support.

  • More inclusive recruiting in order to maintain development.

Furthermore, talent retention may also be aided by organized performance reviews and transparent recognition programs.

(Input from various sources)

(Rehash/Vasudha Handa/MSM)

Alzheimer’s Cause Uncovered: Myelin-Axon Breakdown at the Core

From Seizures to Substance Abuse: The Real Reasons Schools Call Emergency Services

HHS Eliminates CDC Staff Who Made Sure Birth Control Is Safe for Women at Risk

Feds Investigate Hospitals Over Religious Exemptions From Gender-Affirming Care

India Facing a Shortage of Family Physicians – Here's Why